Dzimiri N, Almotrefi A A
Biological and Medical Research Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Arch Int Pharmacodyn Ther. 1991 Nov-Dec;314:34-43.
The inhibitory actions of quinidine and procainamide on the Mg(2+)-dependent ATP hydrolytic action of myocardial Na(+)-K(+)-ATPase (EC 3.6.1.3) were studied in guinea-pig heart preparations incubated in media containing 2.5, 5 and 10 mM of K+. The IC50 values for quinidine were 0.23 +/- 0.02 mM at 2.5 mM K+, 0.56 +/- 0.18 mM at 5 mM K+ and 0.82 +/- 0.05 mM at 10 mM K+, and those of procainamide were 7.2 +/- 1.8 mM at 2.5 mM K+, 13.7 +/- 2.3 mM at 5 mM K+ and 35.5 +/- 3.3 mM at 10 mM K+. Thus, reducing the K+ concentration from the "standard" 5 mM to 2.5 mM showed a significant right-to-left shift in the inhibitory potencies of the drugs, while increasing it to 10 mM resulted in opposite effects. The results show that the inhibitory actions of both drugs on the ATP-hydrolytic action of myocardial Na(+)-K(+)-ATPase depend on the K+ concentration of the incubation medium. These effects seem to be related to the mode by which antiarrhythmic drugs may induce or aggravate cardiac arrhythmias. In addition, the present results suggest that hypokalemia may exacerbate arrhythmias during treatment with these drugs.
在含有2.5、5和10 mM钾离子的培养基中孵育的豚鼠心脏制剂中,研究了奎尼丁和普鲁卡因胺对心肌钠钾ATP酶(EC 3.6.1.3)的镁离子依赖性ATP水解作用的抑制作用。奎尼丁在2.5 mM钾离子浓度下的IC50值为0.23±0.02 mM,在5 mM钾离子浓度下为0.56±0.18 mM,在10 mM钾离子浓度下为0.82±0.05 mM;普鲁卡因胺在2.5 mM钾离子浓度下的IC50值为7.2±1.8 mM,在5 mM钾离子浓度下为13.7±2.3 mM,在10 mM钾离子浓度下为35.5±3.3 mM。因此,将钾离子浓度从“标准”的5 mM降至2.5 mM时,药物的抑制效力出现了显著的从右向左的偏移,而将其增至10 mM则产生相反的效果。结果表明,这两种药物对心肌钠钾ATP酶的ATP水解作用的抑制作用取决于孵育培养基中的钾离子浓度。这些效应似乎与抗心律失常药物可能诱发或加重心律失常的方式有关。此外,目前的结果表明低钾血症可能会在使用这些药物治疗期间加重心律失常。